Kevin thornal hologic

Author: xcui

August undefined, 2024

Web5 jan. 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing … Web1 mrt. 2024 · Kevin R. Thornal serves as Division President, Diagnostics of the …

FDA Expands Approval for Hologic’s HIV Diagnostic - FDAnews

Web“We are thrilled that the Biotheranostics team will become part of Hologic’s diagnostic … Web5 jan. 2024 · Hologic to Acquire Biotheranostics, ... oncology adjacency that fits perfectly with our broader corporate focus and passion for women’s health,” said Kevin Thornal, Hologic’s Division ... la huerta menu

Hologic To Buy Biotheranostics For $230M; Top Analyst Sticks

Web5 jan. 2024 · “Acquiring Biotheranostics enables us to jump-start our entry into a large, … Web17 nov. 2024 · Kevin Thornal is 46, he's been the Division President and Diagnostics of … jelisa anderson

Hologic and Google Cloud Announce Collaboration to Advance …

Hologic’s Cynosure division to present 19 scientific abstracts at …

WebKevin R. Thornal Group President, Global Diagnostic Solutions Essex Mitchell Division President, GYN Surgical Solutions Jan Verstreken Group President, International Patrick Brady Senior Vice President, Global Supply Chain, Quality and Regulatory Lisa Hellmann Senior Vice President, Global Human Resources and Corporate Communications Ryan … Web18 nov. 2024 · Hologic diagnostic solutions division president Kevin Thornal said: “Application of AI requires digital images that are of exceptional quality. “Our teams developed a breakthrough imaging technology that converts physical glass cytology slides into digital images with superior clarity. la huerta market kentWebHologic intends to begin adding Diagenode PCR assays to the Panther Fusion to detect the most prevalent hospital-acquired infections, Thornal said. Additionally, for acute care syndromic testing, it is looking to port over gastrointestinal and respiratory assays, among others, that can quickly differentiate among infections with similar symptoms. jelisa baxter

"Web12 mrt. 2024 · Kevin Thornal Work Experience and Education. According to ZoomInfo … " - Kevin thornal hologic

Kevin thornal hologic

WebKevin R Thornal is Pres:Global Diagnostic Solutions at Hologic Inc. See Kevin R … Web1 feb. 2024 · “Hologic has been at the forefront of cervical cancer screening for more …

Did you know?

WebKevin R Thornal, Hologic Inc: Profile and Biography - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and... Web6 jan. 2024 · Kevin Thornal, president of Hologic’s diagnostics division said, “Acquiring Biotheranostics enables us to jump-start our entry into a large, fast-growing oncology adjacency that fits...

WebView Kevin Thornal's email address (kev*****@hologic.com) and phone number profile as Group President, Global Diagnostic Solutions at Hologic, Inc., located in Marlborough. Find contact's mobile number, email address, work history, and more. WebKevin Thornal President of Hologic's Diagnostic Solutions Division Quote from Joe …

WebCynosure, LLC.’s Post Cynosure, LLC. 33,730 followers 4y Web13 mei 2024 · Hologic Retweeted MedtechStrat Our CEO Stephen MacMillan and our …

Web15 mrt. 2024 · Hologic has already announced this year the acquisitions of …

Web22 feb. 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 … lahuerta lleidaWebAt Hologic, Inc., we promise to treat your data with respect and will not share your … jelisa cafeWeb20 nov. 2024 · - First FDA-Approved Assay for Both Qualitative Diagnosis and Quantitative Viral Load Monitoring - Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has approved a diagnostic claim for its HIV-1 (human immunodeficiency virus type 1) viral load monitoring assay. The Aptima® HIV-1 Quant … jelisa castrodale emailWeb2 apr. 2024 · Kevin Thornal, Divisional President of Cynosure at Hologic. Highlights of … lahuertadepakaWebKevin Thornal, President of Hologic's Diagnostic Solutions Division The only … jelisa carrollWeb22 feb. 2024 · “We are very pleased to complete the acquisition of Biotheranostics and … la huerta menu springdaleWeb22 feb. 2024 · “We are very pleased to complete the acquisition of Biotheranostics and look forward to working with our new colleagues to grow in the large, rapidly expanding oncology space,” said Kevin Thornal,... jelisa castrodale muck rack